Mounjaro and Creatinine: What You Should Know

Creatinine is a waste product cleared by the kidneys; its blood level is a routine marker of kidney function used in clinical monitoring.
GLP-1 and dual GIP/GLP-1 medicines like tirzepatide can cause a modest, often temporary rise in creatinine, usually linked to reduced fluid intake rather than direct kidney harm.
Dehydration from nausea, vomiting or reduced appetite during Mounjaro treatment is the most common reason creatinine climbs — and the most addressable one.
Anyone with pre-existing kidney disease should discuss it with their prescriber before starting tirzepatide; monitoring requirements vary by individual.

Creatinine levels can rise during tirzepatide treatment, and understanding why matters. Mounjaro affects how the kidneys handle fluid and waste — creatinine, a byproduct of muscle metabolism filtered by the kidneys, sometimes reads higher on blood tests while people are on it. That does not automatically signal kidney damage, but it does deserve a closer look. As a prescription-only medicine requiring clinical assessment, tirzepatide is reviewed by a prescriber who takes your full health picture into account, kidneys included.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How tirzepatide interacts with kidney markers, and what to do about it

Step 1: Understand what creatinine is actually telling you

Creatinine is produced constantly as muscles break down creatine phosphate during normal activity. The kidneys filter it from the blood and pass it out in urine, so blood creatinine is used as a straightforward proxy for how well the kidneys are working. A higher reading can mean the kidneys are under strain, or it can mean the person is mildly dehydrated, has lost muscle mass, or has eaten a large amount of meat recently. Context matters enormously.

When someone starts Mounjaro, appetite drops and nausea is common, especially in the first few weeks after starting or increasing the dose. Drinking less (even without noticing) concentrates the blood and raises creatinine without any actual change in kidney function. This is the picture seen most often in clinical monitoring, and it tends to correct once hydration improves. The relationship between Mounjaro and creatinine levels is explored in more detail elsewhere, but the short version is: a small rise on its own, in the context of early treatment, is usually not alarming.

That said, creatinine is not something to wave away. If levels rise substantially, persist, or climb alongside other symptoms, your prescriber needs to know.

Step 2: Know which situations warrant closer monitoring

Severe or prolonged gastrointestinal side effects (persistent vomiting, diarrhoea or both) can dehydrate the body enough to push creatinine up meaningfully. The NHS tirzepatide medicines page lists dehydration and kidney problems among the symptoms that should prompt urgent medical advice: feeling faint, passing very little urine, or having a dry mouth alongside severe GI illness are signs to act on, not wait out.

People who already have reduced kidney function before starting Mounjaro need particular care. Tirzepatide is not contraindicated in mild-to-moderate chronic kidney disease, but the prescriber will weigh the risks and may recommend periodic blood tests during treatment. If you have a history of kidney conditions, dialysis, or take medicines that affect kidney function (certain blood-pressure drugs or NSAIDs, for example) flag this at your consultation. It is also worth noting that questions about creatine supplements and Mounjaro are separate from creatinine monitoring; creatine supplementation raises creatinine independently and can complicate interpretation of blood results.

A practical habit that takes under a minute: check the colour of your first morning urine. Pale straw means you are drinking enough; anything darker than apple juice suggests you need more fluid that day. Simple, but on Mounjaro it is genuinely useful.

Step 3: What this means for how you manage treatment day to day

Staying well hydrated is the single most actionable step most people can take. GLP-1 medicines slow gastric emptying and blunt thirst signals, so active effort to drink water throughout the day matters more than it might have before treatment. Soups, broths and water-rich vegetables all count. The guidance on what to eat on Mounjaro covers practical approaches to eating and drinking during treatment, including how to manage appetite suppression without under-eating protein or fluids.

There is also a muscle-loss dimension worth knowing about. Rapid weight loss on any programme can reduce muscle mass, and since creatinine production comes partly from muscle, people who lose a significant amount of lean tissue may actually see creatinine fall rather than rise, even if kidney function has changed. This is one reason creatinine alone is an imperfect kidney marker during active weight loss, eGFR (estimated glomerular filtration rate), which adjusts for body composition, gives a fuller picture. Your GP or prescriber can request this if needed.

If you are wondering about the separate question of gym supplementation alongside treatment, the tirzepatide and creatine supplement page addresses that in full. And for anyone thinking about the broader picture of Mounjaro's effects on muscle tissue, our page on Mounjaro and muscle loss goes into the evidence. Tirzepatide treatment costs in the private market are covered on our Mounjaro cost page if you are weighing up your options.

Creatinine is one of several markers a clinician considers when assessing whether tirzepatide is right for you. At nume, a GPhC-registered prescriber reviews your full health history before any treatment is approved, including any relevant kidney history. If you have questions about your specific situation, the best place to start is a consultation. Start your free consultation and a prescriber will review your case the same day.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions